AION Biosystems Recognized as Finalist for the Digital Health Hub Foundation – Digital Health & AI Awards 2026 at HLTH

LOWELL, MA, UNITED STATES, October 22, 2026 /EINPresswire.com/ — AION Biosystems, maker of TempShield continuous temperature monitoring (CTM), is thrilled to announce its selection as a finalist for the prestigious Digital Health Hub Foundation – Digital Health & AI Awards 2026 at HLTH. AION was chosen as a finalist for the Home, Hybrid & Remote Care – Rising Star category.

The Digital Health Hub Awards celebrate organizations that demonstrate excellence in leveraging digital advancements to enhance healthcare services and patient outcomes. AION was recognized for its continuous temperature monitoring that changes how care teams use one of medicine’s oldest vital signs. For more than 150 years, temperature has been checked a few times a day and used to confirm an infection after it has already taken hold. TempShield monitors body temperature continuously for up to 90 days, taking 288 readings a day and alerting care teams to early shifts that can signal infection before symptoms appear. The recognition reflects the company’s work to give clinicians earlier warning of infection in high-risk patients, wherever those patients are receiving care.

The Digital Health Hub Foundation Awards honor organizations making strides in improving healthcare speed, efficiency and equity with their digital innovations. Being named a finalist reflects AION’s commitment to driving meaningful change in the healthcare landscape.

“Temperature is one of the earliest signals of decline we have,” said Samara Barend, CEO of AION Biosystems. “For too long we’ve only checked it a few times a day and hoped we didn’t miss anything in between. Being named a Rising Star finalist in home and remote care recognizes where that gap is widest, in between visits or checks.”

From a pool of more than 1,300 submissions, only the most promising companies in each track and category have advanced to this stage.

“The transition from Quarterfinalist to Finalist is where the competition really gets exciting,” said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation. “We’re seeing companies move beyond promising ideas to solutions that are changing how healthcare is delivered, experienced, and accessed. Our finalists represent an extraordinary range of innovation, and we can’t wait to bring their achievements to the stage at HLTH in November.”

The 2026 Digital Health & AI Awards will culminate on Monday, November 16, at HLTH USA at The Venetian in Las Vegas, where winners will be revealed live during three themed awards shows at the Awards Pavilion.

Awards Day at HLTH — Monday, November 16
1:00 PM — Healthcare for Everyone: Access, Care & Community
Recognizing innovation in civic health, caregiving and aging, oral health, and cardiometabolic care.
2:30 PM — The Future of Medicine
Celebrating advancements in cancer detection, therapeutics and pharmacy, and women’s and family health.
5:00 PM — The Future of Health & Intelligent Care
Highlighting transformative care delivery, home and remote care, mental and brain health, and healthy lifespan and longevity.

About Digital Health Hub Foundation
Our mission is to help the world’s next best innovative healthcare companies scale and grow. Founded in 2017, on the campus of UCSF in San Francisco, our now 30,000 member community consists of thousands of early-to late-stage healthcare companies and highly qualified healthcare industry providers, payors, experts, mentors, investors, clinicians and researchers who participate in our annual awards ceremony where we bring together
the industry to honor and validate the best of the best and celebrate the technological advances in healthcare and the impact it has.

About AION Biosystems
For more than 150 years, clinicians have used temperature to confirm an infection after it has already taken hold. AION Biosystems built TempShield to catch it earlier. FDA-cleared, TempShield establishes body temperature as a biomarker for early detection, pairing a first-in-class wearable patch with a clinical intelligence platform that flags infection in high-risk patients before symptoms appear. Care teams get the time to intervene, and hospitalization and mortality drop significantly. AION’s goal is to make continuous temperature monitoring as standard in infection care as continuous glucose monitoring is in diabetes care, so residents and their care teams get the warning instead of the emergency.

Bonni DeWoskin
AION Biosystems
Bonni@AIONBiosystems.com
Visit us on social media:
LinkedIn

Media gallery